Open AccessHIV‐seropositive Individuals' Optimistic Beliefs About Prognosis and Relation to Medication and Safe Sex Adherence
Author(s) -
Holmes William C.,
Pace Joseph L.
Publication year - 2002
Publication title -
journal of general internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.746
H-Index - 180
eISSN - 1525-1497
pISSN - 0884-8734
DOI - 10.1046/j.1525-1497.2002.00746.x
Subject(s) - serostatus , medicine , optimism , life expectancy , psychological intervention , affect (linguistics) , demography , human immunodeficiency virus (hiv) , family medicine , psychiatry , viral load , population , social psychology , psychology , linguistics , philosophy , environmental health , sociology
OBJECTIVE: The study objective was to characterize respondents' prognostic perceptions of HIV infection and to explore how perceptions might affect medication and safe sex nonadherence. METHODS: Surveys were mailed to 295 clients of an HIV‐specific case management organization. Participants were asked to describe experience with HIV/AIDS right after serostatus knowledge and currently, using provided word lists, after which they were asked to assess current life expectancy. Self‐reported information on antiretroviral medication and safe sex nonadherence was obtained. RESULTS: A total of 220 (75%) clients (66% nonwhite, 73% male, 63% gay/bisexual, 50% educated >12 years, and 53% with incomes <$10,000/year) returned surveys. Negative descriptors from word lists were significantly less common and positive descriptors significantly more common now compared to right after serostatus knowledge. Current perceptions about life expectancy indicated that most respondents thought they would live many years, many believing they would live well into old age. Whites (odds ratio [OR], 0.34; P = .01) were less likely and those with >12 years education (OR, 2.76; P = .02) and with CD4 cell counts >200 (OR, 2.70; P = .01) were more likely to have optimistic prognostic beliefs. The optimistic subgroup, when compared with the pessimistic subgroup, was more likely to report medication (26% vs 13%, P = .04) and safe sex (57% vs 29%, P = .004) nonadherence. CONCLUSIONS: Seropositive individuals, including persons of color (adjusted) as well as women and drug users (unadjusted), self‐reported optimistic beliefs about their prognosis. Those with more optimism about their prognosis were significantly more likely to report medication and safe sex nonadherence. A better understanding of seropositive patients' prognostic beliefs and the factors determining them is warranted.